ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 080,74
-0,27%
Dow Jones
39 113,88
0,12%
DAX
18 620,91
-0,35%
Brent Oil
81,765
0,56%
Bitcoin
67 258,08
-0,98%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Epizyme Inc (EPZM)

  7. Epizyme Inc (EPZM) Actualités

EPZM

Epizyme (EPZM)

Epizyme Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EPZM
DateHeureSourceTitreSymboleSociété
14/02/202322h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EPZMEpizyme Inc
17/08/202201h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EPZMEpizyme Inc
15/08/202212h36Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:EPZMEpizyme Inc
15/08/202212h29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:EPZMEpizyme Inc
12/08/202218h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EPZMEpizyme Inc
12/08/202215h24Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:EPZMEpizyme Inc
12/08/202213h53Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:EPZMEpizyme Inc
09/08/202213h00Business WireEpizyme Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:EPZMEpizyme Inc
05/08/202214h17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:EPZMEpizyme Inc
04/08/202222h09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EPZMEpizyme Inc
28/06/202214h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EPZMEpizyme Inc
27/06/202212h36Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:EPZMEpizyme Inc
27/06/202212h22Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:EPZMEpizyme Inc
27/06/202207h01Business WireIpsen to acquire Epizyme, expanding its portfolio in oncologyNASDAQ:EPZMEpizyme Inc
27/06/202207h00Business WireIpsen to Acquire Epizyme, Expanding Its Portfolio in OncologyNASDAQ:EPZMEpizyme Inc
27/06/202207h00Business WireIpsen acquiert Epizyme et étend son portefeuille en OncologieNASDAQ:EPZMEpizyme Inc
02/06/202213h00Business WireEpizyme Presents Updates from SYMPHONY-1 Tazemetostat + R2 Combination Study in Relapsed/Refractory Follicular Lymphoma at the 2022 ASCO Annual MeetingNASDAQ:EPZMEpizyme Inc
17/05/202213h00Business WireEpizyme To Participate in H.C. Wainwright Global Investment ConferenceNASDAQ:EPZMEpizyme Inc
12/05/202212h26TipRanksEpizyme (EPZM) Gets a Buy Rating from H.C. WainwrightNASDAQ:EPZMEpizyme Inc
10/05/202213h28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EPZMEpizyme Inc
10/05/202213h00Business WireEpizyme Reports First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:EPZMEpizyme Inc
04/05/202218h28Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:EPZMEpizyme Inc
03/05/202213h00Business WireEpizyme Announces Date of First Quarter 2022 Financial ResultsNASDAQ:EPZMEpizyme Inc
06/04/202213h00Business WireEpizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EPZMEpizyme Inc
21/03/202223h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EPZMEpizyme Inc
15/03/202212h00Business Wire Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical UpdateNASDAQ:EPZMEpizyme Inc
02/03/202214h00Business WireEpizyme to Participate in Upcoming Healthcare Conferences in MarchNASDAQ:EPZMEpizyme Inc
01/03/202213h00Business WireEpizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateNASDAQ:EPZMEpizyme Inc
22/02/202213h00Business WireEpizyme Announces Date of Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:EPZMEpizyme Inc
27/01/202208h12Business WireEpizyme Announces Pricing of Public Offering of Common StockNASDAQ:EPZMEpizyme Inc
 Showing the most relevant articles for your search:NASDAQ:EPZM

Dernières Valeurs Consultées

EU
D489T
D489T
BIT
P21YH4
NLBNPIT21YH4 20240621 10.5
COIN
DADETH
DAD
BIT
P224X3
NLBNPIT224X3 20240517 30...
IDCM
ARTSBTC
ARTISTA
BIT
UC92TW
Unicredit Bank
EU
EHCS
Croma NV
EU
BE6348197326
Jobmatch
BOV
CGRA3R
GRAZZIOTIN ON
LSE
SPX
Spirax-sarco Engineering
EU
ALBLU
Bluelinea
EU
H843S
H843S
BOV
GSHP3R
GENERAL SHOP ON
BOV
GOLL11
GOL PN
BOV
GOLL4Q
GOL PN
EU
U776S
U776S
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés